What is the recommended N‑acetylcysteine (NAC) dose for a patient who ingested anticoagulant rodenticide (rat poison)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NAC is NOT indicated for anticoagulant rodenticide poisoning

N-acetylcysteine (NAC) has no role in the treatment of anticoagulant rodenticide poisoning, as it is a specific antidote only for acetaminophen toxicity and does not address the mechanism of anticoagulant rodenticides. 1

Mechanism and Rationale

  • NAC works exclusively by replenishing glutathione stores and preventing formation of the toxic acetaminophen metabolite NAPQI—mechanisms completely irrelevant to rodenticide poisoning 1, 2
  • Anticoagulant rodenticides inhibit vitamin K₁-2,3-epoxide reductase, blocking synthesis of clotting factors II, VII, IX, and X—a pathway unaffected by NAC 3
  • Administering NAC for rodenticide poisoning would be ineffective and potentially delay appropriate treatment 1

Correct Management of Anticoagulant Rodenticide Poisoning

Immediate Triage Decisions

  • Refer immediately to emergency department if exposure involves suspected self-harm, abuse, misuse, or malicious administration regardless of dose 4
  • Refer immediately if patient has any symptoms of anticoagulant toxicity (bleeding, bruising) regardless of dose 4
  • Refer immediately for chronic ingestion to evaluate intent and potential coagulopathy 4

Risk Stratification by Dose

  • Unintentional ingestion <1 mg active ingredient: Safe observation at home without laboratory monitoring (includes practically all unintentional pediatric ingestions) 4
  • Unintentional ingestion ≥1 mg active ingredient: Evaluate for coagulopathy at 48-72 hours post-exposure 4
  • Patients on therapeutic anticoagulants who ingest any dose should have baseline PT/INR and repeat at 48-72 hours 4

Definitive Treatment Protocol

For elevated INR without active bleeding:

  • INR <4.0: No treatment required 3
  • INR ≥4.0: Phytomenadione (vitamin K₁) 10 mg IV (100 mcg/kg for children) 3

For active bleeding:

  • Prothrombin complex concentrate 50 units/kg (preferred—contains factors II, VII, IX, X) 3
  • OR recombinant activated factor VII 1.2-4.8 mg 3
  • OR fresh frozen plasma 15 mL/kg if concentrate unavailable 3
  • PLUS phytomenadione 10 mg IV (100 mcg/kg for children) 3

Laboratory Monitoring

  • Measure INR at 36-48 hours post-exposure for all cases except low-dose unintentional pediatric ingestions 3
  • If INR normal at 48-72 hours, even with long-acting formulations, no further action required 3
  • Outpatient facilities must obtain coagulation results within 24 hours 4

Critical Pitfalls to Avoid

  • Do not administer vitamin K prophylactically before evaluation for coagulopathy 4
  • Do not use ipecac or gastric lavage for decontamination 4
  • Do not delay ED transport to administer activated charcoal 4
  • Long-acting anticoagulant rodenticides (brodifacoum, bromadiolone, difenacoum) may cause anticoagulation for weeks to months after substantial ingestion due to high lipid solubility and enterohepatic circulation 3

Exception: Co-Ingestion Scenario

Only consider NAC if documented or suspected acetaminophen co-ingestion with rodenticide 1:

  • Oral NAC: 140 mg/kg loading dose, then 70 mg/kg every 4 hours for 17 doses 1
  • IV NAC: 150 mg/kg over 15 minutes, then 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours 1

Conflicting Research Evidence

While two retrospective studies 5, 6 suggested potential survival benefits of NAC in rodenticide poisoning, these findings contradict established pharmacological mechanisms and guideline recommendations. The proposed benefit lacks biological plausibility given NAC's specific mechanism of action in acetaminophen toxicity 1, 2. Contact your regional poison control center immediately for specific guidance on the particular rodenticide involved 1.

References

Guideline

NAC Dosing in Rodenticide Poisoning

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anticoagulant rodenticides.

Toxicological reviews, 2005

Research

N-Acetyl Cysteine in Rodenticide Poisoning: A Systematic Review and Meta-Analysis.

Current reviews in clinical and experimental pharmacology, 2022

Related Questions

What is the management approach for a patient with suspected rat poison ingestion, particularly those with potential bleeding complications and impaired coagulation?
How to dilute N-acetylcysteine (NAC) in a patient with myocarditis secondary to rodenticide consumption, elevated Central Venous Pressure (CVP) indicating potential fluid overload, and risk of heart failure?
What is the recommended treatment with N-acetylcysteine (NAC) infusion for a patient with deliberate self-harm involving yellow phosphorus rodenticide?
What is the recommended dosage of N-acetylcysteine (NAC) for an adult patient with deliberate self-harm involving yellow phosphorus rodenticide poisoning?
What is the treatment for anticoagulant rodenticide (rat killer) poisoning?
What are the latest guideline recommendations for the duration of dual antiplatelet therapy after drug‑eluting stent implantation in stable coronary disease versus acute coronary syndrome, and how should bleeding risk or concomitant oral anticoagulation modify the regimen?
Which adult patients with esophageal or proximal gastric subepithelial tumors ≤ 3 cm, without coagulopathy, extensive fibrosis, or prior radiation, are appropriate candidates for submucosal tunneling endoscopic resection (STER) and what are its contraindications?
When can a mechanically ventilated patient be weaned if they are hemodynamically stable (no or low‑dose vasopressor support, heart rate 60‑120 bpm, systolic blood pressure >90 mm Hg), have adequate oxygenation (fraction of inspired oxygen ≤0.40, positive end‑expiratory pressure ≤5 cm H₂O, PaO₂/FiO₂ ratio >150‑200 mm Hg), acceptable ventilation (PaCO₂ ≤50 mm Hg, pH ≥7.25), and are neurologically alert (awake, following commands, intact gag reflex) with an improving underlying cause?
What activity restrictions are recommended for a male patient with an inguinal hernia, both before and after surgical repair?
Can a serum potassium of 2.9 mEq/L cause cardiac arrest?
What new cellular treatment options are available and appropriate for a patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.